It was Christmas come early for publicly funded TB programs and for advocates of improved tuberculosis regimens when the maker of a rifapentine, a drug that can shorten treatment for tuberculosis infection from as much as nine months to three months announced Thursday it will drop its price for the medicine to a dollar a […]
HIV
As the federal Ending the HIV epidemic takes form, experts talk details, challenges: “How do we get there from here?” WASHINGTON, DC – Nearly four decades […]
Tuberculosis
But with a $3.3 billion shortfall in funding, gaps in treatment and prevention among the most vulnerable still take 4,000 lives a day For the first […]
Research & Development
While a World Health Organization-led strategy aims to provide 1.4 billion doses of vaccine against yellow fever to achieve 80% vaccination coverage across countries by 2026 […]
Policy
The following is a guest post by Jay Gribble of Health Policy Plus and Alyson Lipsky of RTI and Health Policy Plus Donors, implementers, and governments […]